Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+57.2%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+57.2%/yr
vs +2.4%/yr prior
Acceleration
+54.8pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
3.9x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.45M | +16.1% |
| 2024 | $9.87M | +16.0% |
| 2023 | $8.51M | +188.8% |
| 2022 | $2.95M | +358.0% |
| 2021 | $-1.14M | -169.3% |
| 2020 | $-424000.00 | +82.9% |
| 2019 | $-2.48M | -192.8% |
| 2018 | $2.68M | +116.7% |
| 2017 | $-15.99M | -3377.0% |
| 2016 | $488000.00 | - |